MANJUSHA GAGLANI to Hemagglutinin Glycoproteins, Influenza Virus
This is a "connection" page, showing publications MANJUSHA GAGLANI has written about Hemagglutinin Glycoproteins, Influenza Virus.
Connection Strength
0.470
-
Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel. Vaccine. 2025 Aug 13; 61:127361.
Score: 0.224
-
Molecular features of the serological IgG repertoire elicited by egg-based, cell-based, or recombinant haemagglutinin-based seasonal influenza vaccines: a comparative, prospective, observational cohort study. Lancet Microbe. 2025 Feb; 6(2):100935.
Score: 0.216
-
Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. J Infect Dis. 2016 10 01; 214(7):1010-9.
Score: 0.030